By: Price (Senate Sponsor - Kolkhorst) H.C.R. No. 76
(In the Senate - Received from the House May 13, 2019;
May 14, 2019, read first time and referred to Committee on
Administration; May 19, 2019, reported favorably by the following
vote: Yeas 5, Nays 0; May 19, 2019, sent to printer.)
Click here to see the committee vote
HOUSE CONCURRENT RESOLUTION
WHEREAS, Tardive dyskinesia (TD) is a condition
characterized by involuntary movements of the face, trunk, or
extremities, caused by long-term use of dopamine receptor-blocking
agents; and
WHEREAS, A movement disorder, TD is most commonly associated
with facial symptoms such as uncontrolled grimacing, abnormal
motions of the lips and tongue, and rapid blinking, but may also
manifest in other parts of the body; it occurs in patients who have
been prescribed neuroleptic medications for schizophrenia, bipolar
disorder, other neurological conditions, and gastrointestinal
disorders, and it can persist after individuals discontinue use of
the drugs; and
WHEREAS, Patients living with TD frequently suffer from
embarrassment due to their involuntary movements, which may create
a sense of discomfort and unease in those around them; these
struggles often compound the difficulties that individuals with TD
already face while being treated for psychiatric and mood
disorders, leading them to further isolate themselves from others;
the condition can also make it challenging for patients to work and
stay active and productive; and
WHEREAS, TD is estimated to affect at least 500,000 people in
the United States, and it is more prevalent among postmenopausal
women, patients over the age of 55, and those with a history of
alcohol or substance abuse; it is important that patients be
diagnosed as early as possible to ensure the best outcome, and at
this time, prevention remains the best-established method for
combatting the condition; and
WHEREAS, Awareness among patients, medical professionals,
caregivers, and the public can play a crucial role in helping more
people to live lives free of TD and the challenges and stigma
associated with it, and the observance of TD Awareness Week in May
2019 will assist in promoting much-needed education on this
important health issue; now, therefore, be it
RESOLVED, That the 86th Legislature of the State of Texas
hereby designate the first full week of May as TD Awareness Week and
encourage all Texans to learn more about the risk factors and signs
of tardive dyskinesia; and, be it further
RESOLVED, That, in accordance with the provisions of Section
391.004(d), Government Code, this designation remain in effect
until the 10th anniversary of the date this resolution is finally
passed by the legislature.
* * * * *